Clinical Trials List
Protocol Number222638
Not yet recruiting
2025-12-01 - 2029-01-04
Phase II
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chung-Hao Huang Division of Infectious Disease
- Yen-Hsu Chen Division of Infectious Disease
- 梁智瑋 Division of Infectious Disease
- Tun-Chieh Chen Division of Infectious Disease
- Chun-Yu Lin Division of Infectious Disease
- Chun-Yuan Lee Division of Infectious Disease
- 呂其融 Division of Infectious Disease
- Shang-Yi Lin Division of Infectious Disease
Co-Principal Investigator
- 劉思妤 Division of Infectious Disease
- Chien Chuang Division of Infectious Disease
- YI-TSUNG LIN Division of Infectious Disease
- 陳昕白 Division of Infectious Disease
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
150 participants
